Development of CYP450-expressing human bronchial epithelial cell lines for in vitro pharmacotoxicologic applications

In Vitro and Molecular Toxicology: Journal of Basic and Applied Research

Volumn 10, Issue 1, 1997, Pages 85-92

  Macé, Katherine ^a   Vautravers, Patricia ^a   Granato, Dominique ^a   Gonzalez, Frank J ^b   Harris, Curtis C ^c   Pfeifer, Andrea M A ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; COMPLEMENTARY DNA; COUMARIN DERIVATIVE; CYTOCHROME P450; DIMETHYLNITROSAMINE; RESORUFIN DERIVATIVE;

BRONCHUS MUCOSA; CELL LINE; CONFERENCE PAPER; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING;

EID: 0031007641     PISSN: 10979336     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. AOYAMA, T., YAMANO, S., WAXMAN, D.J., LAPENSON, D.P., MEYER, U.A., FISHER, V., TYNDALE, R., INABA, T., WERNER, K., GELBOIN, H.V., and GONZALEZ, F.J. (1989). Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver: cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine. J. Biol. Chem. 264, 10388-10395.
2. BERTHOU, F., GOASDUFF, T., LUCAS, D., DREANO, Y., LE BOT, M.H., and MÉNEZ, J.F. (1995). Interaction between two probes used for phenotyping cytochrome P450 1A2 (caffeine) and P450 2E1 (chlorzoxazone) in humans. Pharmacogenetics 5, 72-79.
3. CRESPI, C.L., PENMAN, B.W., GELBOIN, H.V., and GONZALEZ, F.J. (1991). A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6. Carcinogenesis 12, 1197-1201.
4. CRESPI, C.L., PENMAN, B.W., LEAKEY, J.A.E., ARLOTTO, M.P., STARK, A., PARKINSON, A., TURNER, T., STEIMEL, D.T., RUDO, K., DAVIES, R.L., and LANGENBACH, R. (1990). Human cytochrome P450IIA3: cDNA sequence, role of the enzyme in the metabolic activation of promutagens, comparison to nitrosamine activation by human cytochrome P450IIE1. Carcinogenesis 11, 1293-1300.
5. DONATO, M.T., CASTELL, J.V., and GOMEZ-LECHON, M.J. (1995). Effect of model inducers on cytochrome P450 activities of human hepatocytes in primary culture. Drug Metab. Dispos. 23, 553-558.
6. FELLEY-BOSCO, E., MIRKOVITCH, J., AMBS, S., MACÉ, K., PFEIFER, A., KEEPER, L.K., and HARRIS, C.C. (1995). Nitric oxide and ethylnitrosurea: Relative mutagenicity in the p53 tumor suppressor and hypoxanthine-phosphoribosyltransferase genes. Carcinogenesis 16, 2069-2074.
7. GONZALEZ, F.J., CRESPI, C.L., and GELBOIN, H.V. (1991). cDNA-expressed human cytochrome P450s: A new age of molecular toxicology and human risk assessment. Mutat. Res. 247, 113-127.
8. GONZALEZ, F.J., SKODA, R.C., KIMURA, S., UMENO, M., ZANGER, U.M., NEBERT, D.W., GELBOIN, H.V., HARDWICK, J.P., and MEYER, U.A. (1988a). Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature 331, 442-446.
9. GONZALEZ, F.J., B.J. UMENO, M., MCBRIDE, O.W., HARDWICK, J.P., MEYER, U.A., GELBOIN, H.V., and IDLE, J.R. (1988b). Human P450PCN1: Sequence, chromosome, localization and direct evidence through cDNA expression that P450PCN1 is nifedipine oxidase. DNA 7, 76-86.
10. LECHNER, J.F., HAUGEN, A., MCCLENDON, I.A., and PETTIS, E.W. (1982). Clonal growth of normal adult human bronchial epithelial cells in a serum-free medium. In Vitro 18, 633-642.
11. LECHNER, J.F., and LA VECK, M.A. (1985). A serum-free method for culturing normal human bronchial epithelial cells at clonal density. J. Tissue Culture Methods 9, 43-48.
12. MACÉ, K., GONZALEZ, F.J., MCCONNELL, I.R., GARNER, R.C., AVANTI, O., HARRIS, C.C., and PFEIFER, A.M.A. (1994). Activation of promutagens in a human bronchial epithelial cell line stably expressing human cytochrome P450 1A2. Mol. Carcinogen. 11, 65-73.
13. MACÉ, K., OFFORD, E.A., and PFEIFER, A.M.A. (1996). Drug metabolism and carcinogen activation studies with human genetically engineered cells, in: In Vitro Methods in Pharmceutical Research. J.V. Castell and M.J. Gomez-Lechon (eds.) Academic Press: London, pp. 433-456.
14. OFFORD, E.A., MACÉ, K., AVANTI, O., and PFEIFER, A.M.A. (1996). Mechanisms involved in the chemoprotective effects of rosemary extract studied in human liver and bronchial cells. Cancer Lett. In Press.
15. OFFORD, E.A., MACÉ, K., RUFFIEUX, C., MALNOË, A., and PFEIFER, A.M.A. (1995). Rosemary components inhibit benzo(a)pyrene-induced genotoxicity in human bronchial cells. Carcinogenesis 16, 2057-2062.
16. PENMAN, B.W., REECE, J., SMITH, T., YANG, C.S., GELBOIN, H.V., GONZALEZ, F.J., and CRESPI, C.L. (1993). Characterization of a human cell line expressing high levels of cDNA-derived CYP2D6. Pharmacogenetics 3, 28-39.
17. PFEIFER, A., MARK, G.E., MALAN-SHIBLEY, L., GRAZIANO, S.L., AMSTAD, P., and HARRIS, C.C. (1989). Cooperation of c-ras-1 and c-myc protooncogenes in the neoplastic transformation of SV40 T-antigen immortalized human bronchial epithelial cells. Proc. Natl. Acad. Sci. USA 86, 10075-10079.
18. REDDEL, R.R., KE, Y., GERWIN, B.I., MCMENAMIN, M.G., LECHNER, J.F., SU, R.T., BRASH, D.E., PARK, J.B., RHIM, J.S., and HARRIS, C.C. (1988). Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate co-precipitation with a plasmid containing SV40 early region genes. Cancer Res. 48, 1904-1909.
19. SONG, B.-J., GELBOIN, H.V., PARK, S.-S., YANG, C.S., and GONZALEZ, F.J. (1986). Complementary DNA and protein sequences of ethanol-inducible rat and human cytochrome P450s. J. Biol. Chem. 261, 16689-16697.
20. STRAUSS, G.H., and ALBERTINI, R.J. (1979). Enumeration of 6-thioguanine-resistant peripheral blood lymphocytes in man as a potential test for somatic cell mutations arising in vivo. Mutat. Res. 61, 353-379.
21. WAXMAN, D.J., LAPENSON, D.P., AOYAMA, T., GELBOIN, H.V., GONZALEZ, F.J., and KORZEKWA, K. (1991). Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochromes P450s. Arch. Biochem. Biophys. 290, 100-166.
22. WRIGHTON, S.A., BRIAN, W.R., SARI, M.-A., IWASAKI, M., GUENGERICH, F.P., RAUCY, J.L., MOLOWA, D.T., and VANDENBRANDEN, M. (1990). Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3). Mol. Pharmacol. 38, 207-213.
23. WRIGHTON, S.A., RING, B.J., WATKINS, P.B., and VANDENBRANDEN, M. (1989). Identification of a polymorphically expressed member of the human cytochrome P-450III family. J. Biol. Chem. 36, 97-105.
24. YAMANO, S., NHAMBURO, P.T., AOYAMA, T., MEYER, U.A., INABA, T., KALOW, W., GELBOIN, H.V., MCBRIDE, O.W., and GONZALEZ, F.J. (1989). cDNA cloning and sequence and cDNA-directed expression of human P450 IIB1: Identification of a normal and two variant cDNAs derived from the CYP2B locus on chromosome 19 and differential expression of the IIB mRNAs in human liver. Biochemisty 28, 7340-7348.
25. YAMANO, S., TATSUNO, J., and GONZALEZ, F.J. (1990). The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. Biochemistry 29, 1322-1329.
26. YOO, J.-S.H., GUENGERICH, F.P., and YANG, C.S. (1988). Metabolism of N-Nitrosodialkylamines by human liver microsomes. Cancer Res. 88, 1499-1504.